Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56M
-
Number of holders
-
211
-
Total 13F shares, excl. options
-
50.3M
-
Shares change
-
+1.48M
-
Total reported value, excl. options
-
$1.19B
-
Value change
-
+$47.1M
-
Put/Call ratio
-
0.36
-
Number of buys
-
116
-
Number of sells
-
-88
-
Price
-
$23.75
Significant Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q2 2020
242 filings reported holding SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q2 2020.
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) has 211 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50.3M shares
of 56M outstanding shares and own 89.79% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8.9M shares), VANGUARD GROUP INC (5.42M shares), ARMISTICE CAPITAL, LLC (2.21M shares), DIMENSIONAL FUND ADVISORS LP (1.96M shares), MACQUARIE GROUP LTD (1.87M shares), STATE STREET CORP (1.84M shares), RENAISSANCE TECHNOLOGIES LLC (1.59M shares), Aristotle Capital Boston, LLC (1.03M shares), FULLER & THALER ASSET MANAGEMENT, INC. (957K shares), and RICE HALL JAMES & ASSOCIATES, LLC (925K shares).
This table shows the top 211 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.